Lactate-associated fibroblast-macrophage signaling in idiopathic pulmonary fibrosis: evidence boundaries and immunopharmacological opportunities.

Wu Y, Song X, Liu B, Han Y, Zheng C, Zhao X, Zhu T, Yuan M, Li H, Wang Y

Open source

DOI
10.3389/fphar.2026.1989965
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1989965,
  title = {Lactate-associated fibroblast-macrophage signaling in idiopathic pulmonary fibrosis: evidence boundaries and immunopharmacological opportunities.},
  author = {Wu Y and Song X and Liu B and Han Y and Zheng C and Zhao X and Zhu T and Yuan M and Li H and Wang Y},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1989965},
  url = {https://doi.org/10.3389/fphar.2026.1989965}
}

RIS

TY  - JOUR
TI  - Lactate-associated fibroblast-macrophage signaling in idiopathic pulmonary fibrosis: evidence boundaries and immunopharmacological opportunities.
AU  - Wu Y
AU  - Song X
AU  - Liu B
AU  - Han Y
AU  - Zheng C
AU  - Zhao X
AU  - Zhu T
AU  - Yuan M
AU  - Li H
AU  - Wang Y
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1989965
UR  - https://doi.org/10.3389/fphar.2026.1989965
ER  - 

APA

Y, W., X, S., B, L., Y, H., C, Z., X, Z., T, Z., M, Y., H, L., & Y, W. (2026). Lactate-associated fibroblast-macrophage signaling in idiopathic pulmonary fibrosis: evidence boundaries and immunopharmacological opportunities.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1989965

Source records